Taiwan Semiconductor Up Over 5%, On Track for Record High — Data Talk
Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM) is currently at $140.71, up $6.81 or 5.09%
--Would be new all-time high (Based on available data back to Oct. 8, 1997)
--Would be the first record close since Jan. 14, 2022, when it closed at $140.66
--On pace for largest percent increase since Feb. 8, 2024, when it rose 7%
--Currently up three consecutive days; up 10.46% over this period
--Best three day stretch since the three days ending Feb. 9, 2024, when it rose 11.5%
--Up 35.3% year-to-date
--Up 57.08% from 52 weeks ago (March 6, 2023), when it closed at $89.58
--Would be a new 52-week closing high
--Up 71.08% from its 52-week closing low of $82.25 on April 26, 2023
--Traded as high as $141.99; highest intraday level since Jan. 14, 2022, when it hit $143.88
--Up 6.04% at today's intraday high
All data as of 9:48:16 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 04, 2024 10:07 ET (15:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track